Navigation Links
Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
Date:1/11/2012

BLUE BELL, Pa., Jan. 11, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), which is revolutionizing vaccines to fight cancers and infectious diseases, announced today that Dr. J. Joseph Kim, President and CEO, will present an overview of the company at Noble Financials 8th Annual Equity Conference.

Noble Financial 8th Annual Equity Conference

January 17-18

Hollywood, FL

Hard Rock Hotel

 

Inovio Presentation

Tuesday, January 17

1:30 pm EST

Noble Financials 8th Annual Equity Conference Website

About Inovio Pharmaceuticals, Inc.

Inovio is developing its revolutionary vaccines to extend the profound medical benefits of the 20th century's immune-system-stimulating vaccines by preventing and treating today's cancers and challenging infectious diseases. Its SynCon® vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile. Inovio's clinical programs include Phase II studies for cervical dysplasia, leukemia and hepatitis C virus and Phase I studies for influenza and HIV. Partners and collaborators include the University of Pennsylvania, Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, US Dept. of Homeland Security and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements rel
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference
2. Inovio Pharmaceuticals Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease
3. Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV
4. Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
5. Inovio Pharmaceuticals Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
6. Inovio Pharmaceuticals DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
7. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
10. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
11. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Research and ... addition of the "Injectable Drug Delivery ... Devices [Disposables & Reusable, Fillable & Prefilled, ... Therapeutics [Diabetes & Oncology] - Global Forecasts ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ...
(Date:6/18/2013)... 2013 As a leading provider ... announces the release of their infographic - " ... , MeMD's goal was to leverage an information ... 2.0, Health 3.0 and mHealth.The infographic features a ... care and the fitness industry in unimaginable ways; ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Though health ... 11,000, according to the U.S. Bureau of Labor Statistics -- ... of 24,000 per month. Most new health care jobs were ... hospital sector saw a loss of 6,000 jobs. Overall, the ... consultancy firm Challenger, Gray & Christmas reported that a total ...
(Date:6/18/2013)... New user friendly innovations in table top ... dangers of misuse and ineffective sterilization. Older autoclave ... hot surfaces and complex door latches. Whether one ... Revolutionary Science explains some important points to remember. , ... will recycle dirty water. This method can be ...
Breaking Biology Technology:Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... Aug. 11, 2011 SimPL, the Simple Platform for ... delivering up-to-date regulatory training , eLearning ... Healthcare administrators and educators spend a great ... SimPL is for those organizations that want a system ...
... Cord Blood America, Inc . ( www.cordblood-america.com ) (OTC Bulletin ... stem cell preservation company focused on bringing the life ... today announced revenues of $2.89 million for the first six ... $1.79 million in the same period in 2010.  Revenues for ...
... Pharma IQ is pioneering new compound management discussion ... Compound Management and Integrity Online event, which will take ... 5 weeks, beginning 31 st   of ... process is high on the agenda for many organisations and this ...
Cached Biology Technology:The SimPL Learning Management System Supports Compliance in Healthcare Facilities 2Cord Blood America Six Month Revenues Up 61 Percent; Gross Profit Up 100 Percent 2Cord Blood America Six Month Revenues Up 61 Percent; Gross Profit Up 100 Percent 3Compound Management and Integrity Goes Online 2Compound Management and Integrity Goes Online 3
(Date:6/17/2013)... alcohol produced by fungi, bacteria, and algae, is a ... is also used in the medical field it,s ... out excess fluids and used during surgery as a ... passage of other drugs. , Now Profs. Ehud Gazit ... Molecular Microbiology and Biotechnology and the Sagol School of ...
(Date:6/17/2013)... gas, is widespread across Pennsylvania, covering up to 280,000 ... Annals of the New York Academy of Sciences ... from toxic chemicals, the building of well pads and ... engendered a great deal of controversy, largely because of ... diversity and resources have scarcely been addressed in the ...
(Date:6/16/2013)... million years ago triggered a similar marine ecosystem crisis ... of global warming, according to research published today in ... from the universities of Newcastle, UK, Cologne, Frankfurt and ... crash in the marine ecosystem during the mid-Cretaceous greenhouse ... time the amplitude and duration of the temperature change.,Analysing ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Global cooling as significant as global warming 2
... travel ... documents, DALLAS, Dec. 19 ... -- also known as ePassports --,it also recognized there was an opportunity ... Entrust, Inc. (Nasdaq:,ENTU) to provide the public key infrastructure (PKI)-enabled digital,signatures., ...
... the Montreal Neurological Institute of McGill University and the ... Music and Sound Research (BRAMS), has found that tone-deaf ... regions of the brain related to processing musical pitch, ... auditory cortex, as compared to those who are musically ...
... -- Two deadly and highly infectious viruses -- both potential ... new drug developed by scientists at Weill Cornell Medical College ... related, newly recognized zoonotic viruses that can spread from their ... pigs, horses and humans. The mode of transmission ...
Cached Biology News:Entrust Digital Signatures Help Secure More Than 18 Million U.S. ePassports 2Entrust Digital Signatures Help Secure More Than 18 Million U.S. ePassports 3Entrust Digital Signatures Help Secure More Than 18 Million U.S. ePassports 4Jingle bells not merry for tone-deaf individuals 2Jingle bells not merry for tone-deaf individuals 3Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 2Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 3
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
Component in MasterPure™ Purification Kits...
... (X/R) Red System consists of concentrated ... and X/R Red Buffer. The X/R ... to produce red staining that may ... , Buffer, 100 mL , Chromogen, ...
... Signets FAST RED Chromogen System ... and substrate buffer. FAST RED ... alkaline phosphatase to produce red ... The FAST ...
Biology Products: